Literature DB >> 24029689

Parkin plays a role in sporadic Parkinson's disease.

Ted M Dawson1, Valina L Dawson.   

Abstract

BACKGROUND: Parkinson's disease (PD) is a chronic progressive neurologic disorder, which affects approximately one million men and women in the US alone. PD represents a heterogeneous disorder with common clinical manifestations and, for the most part, common neuropathological findings.
OBJECTIVE: This short article reviews the role of the ubiquitin E3 ligase in sporadic PD.
METHODS: The role of parkin in sporadic PD was reviewed by querying PubMed.
RESULTS: Parkin is inactivated in sporadic PD via S-nitrosylation, oxidative and dopaminergic stress, and phosphorylation by the stress-activated kinase c-Abl, leading to the accumulation of AIMP2 and PARIS (ZNF746).
CONCLUSION: Strategies aimed at maintaining parkin in a catalytically active state or interfering with the toxicity of AIMP2 and PARIS (ZNF746) offer new therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24029689      PMCID: PMC3984465          DOI: 10.1159/000354307

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  24 in total

1.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.

Authors:  Dongdong Yao; Zezong Gu; Tomohiro Nakamura; Zhong-Qing Shi; Yuliang Ma; Benjamin Gaston; Lisa A Palmer; Edward M Rockenstein; Zhuohua Zhang; Eliezer Masliah; Takashi Uehara; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

2.  NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.

Authors:  Mi Young Kim; Steven Mauro; Nicolas Gévry; John T Lis; W Lee Kraus
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

Review 3.  What genetics tells us about the causes and mechanisms of Parkinson's disease.

Authors:  Olga Corti; Suzanne Lesage; Alexis Brice
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

4.  PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

Authors:  Joo-Ho Shin; Han Seok Ko; Hochul Kang; Yunjong Lee; Yun-Il Lee; Olga Pletinkova; Juan C Troconso; Valina L Dawson; Ted M Dawson
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

6.  Parkin: a multifaceted ubiquitin ligase.

Authors:  D J Moore
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

7.  Dopamine covalently modifies and functionally inactivates parkin.

Authors:  Matthew J LaVoie; Beth L Ostaszewski; Andreas Weihofen; Michael G Schlossmacher; Dennis J Selkoe
Journal:  Nat Med       Date:  2005-10-16       Impact factor: 53.440

8.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

Review 9.  Parkin's substrates and the pathways leading to neuronal damage.

Authors:  Mark R Cookson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

10.  Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation.

Authors:  Fanjun Meng; Dongdong Yao; Yang Shi; Jonathan Kabakoff; Wei Wu; Joshua Reicher; Yuliang Ma; Bernd Moosmann; Eliezer Masliah; Stuart A Lipton; Zezong Gu
Journal:  Mol Neurodegener       Date:  2011-05-19       Impact factor: 14.195

View more
  37 in total

1.  Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Authors:  Saurav Brahmachari; Saebom Lee; Sangjune Kim; Changqing Yuan; Senthilkumar S Karuppagounder; Preston Ge; Rosa Shi; Esther J Kim; Alex Liu; Donghoon Kim; Stephan Quintin; Haisong Jiang; Manoj Kumar; Seung Pil Yun; Tae-In Kam; Xiaobo Mao; Yunjong Lee; Deborah A Swing; Lino Tessarollo; Han Seok Ko; Valina L Dawson; Ted M Dawson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

2.  Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.

Authors:  Alexandra Isabel Rosa; Sara Duarte-Silva; Anabela Silva-Fernandes; Maria João Nunes; Andreia Neves Carvalho; Elsa Rodrigues; Maria João Gama; Cecília Maria Pereira Rodrigues; Patrícia Maciel; Margarida Castro-Caldas
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

Review 3.  The c-Abl inhibitor in Parkinson disease.

Authors:  Zhi-Hua Zhou; Yun-Fan Wu; Xue-Min Wang; Yong-Zhu Han
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

4.  E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.

Authors:  Craig T Werner; Rathipriya Viswanathan; Jennifer A Martin; Pedro H Gobira; Swarup Mitra; Shruthi A Thomas; Zi-Jun Wang; Jian-Feng Liu; Andrew F Stewart; Rachael L Neve; Jun-Xu Li; Amy M Gancarz; David M Dietz
Journal:  Biol Psychiatry       Date:  2018-07-21       Impact factor: 13.382

5.  A specific subset of E2 ubiquitin-conjugating enzymes regulate Parkin activation and mitophagy differently.

Authors:  Fabienne C Fiesel; Elisabeth L Moussaud-Lamodière; Maya Ando; Wolfdieter Springer
Journal:  J Cell Sci       Date:  2014-06-13       Impact factor: 5.285

6.  STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.

Authors:  Pradeep K Kurup; Jian Xu; Rita Alexandra Videira; Chimezie Ononenyi; Graça Baltazar; Paul J Lombroso; Angus C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

7.  Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.

Authors:  Xiaotian Sun; Pascaline Aimé; David Dai; Nagendran Ramalingam; John F Crary; Robert E Burke; Lloyd A Greene; Oren A Levy
Journal:  Exp Neurol       Date:  2018-02-09       Impact factor: 5.330

Review 8.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

9.  Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.

Authors:  Saurav Brahmachari; Preston Ge; Su Hyun Lee; Donghoon Kim; Senthilkumar S Karuppagounder; Manoj Kumar; Xiaobo Mao; Joo Ho Shin; Yunjong Lee; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

10.  Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.

Authors:  Daniel A Stevens; Yunjong Lee; Ho Chul Kang; Byoung Dae Lee; Yun-Il Lee; Aaron Bower; Haisong Jiang; Sung-Ung Kang; Shaida A Andrabi; Valina L Dawson; Joo-Ho Shin; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.